临床评估评分-15在儿童睡眠呼吸障碍中的普适性
结论认为CAS-15可作为评估儿童睡眠呼吸障碍的实用门诊工具。
要点
- CAS-15与AHI呈中等正相关(r=0.41),可作为门诊评估工具。
- 评分≥32预测阳性多导睡眠图的灵敏度69.0%、特异度63.4%。
- 手术患儿术后CAS-15平均变化30.5(SD 12.6),效应量3.1。
核心结论
- 本研究证实CAS-15作为评估儿童睡眠呼吸障碍的门诊工具具有普适性。
主要发现
- 初始CAS-15平均37.3(SD 12.7),n=508。
- 预测阳性多导睡眠图(AHI>2)的ROC曲线下面积0.71(95%CI 0.63-0.80)。
- 评分≥32预测阳性多导睡眠图的灵敏度69.0%(95%CI 61.7-75.5),特异度63.4%(95%CI 47.9-76.6),阳性预测值88.7%(95%CI 82.1-93.1),阴性预测值32.9%(95%CI 23.5-44.0)。
关键数值与推荐
- CAS-15评分≥32用于预测阳性多导睡眠图(AHI>2),灵敏度69.0%、特异度63.4%。
临床怎么用
- CAS-15可作为门诊评估儿童睡眠呼吸障碍的实用工具,帮助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Clinical Assessment Score-15 (CAS-15) has been validated as an office-based assessment for pediatric sleep-disordered breathing in otherwise healthy children. Our objective was to determine the generalizability of the CAS-15 in a multi-institutional fashion. METHODS: Five hundred and thirty children from 13 sites with suspected sleep-disordered breathing were recruited, and the investigators completed the CAS-15. Based on decisions made in the course of clinical care, investigators recommended overnight polysomnography, observation, medical therapy, and/or surgery. Two hundred and forty-seven subjects had a follow-up CAS-15. RESULTS: Mean age was 5.1 (2.6) years; 54.2% were male; 39.1% were white; and 37.0% were African American. Initial mean (standard deviation [SD]) CAS-15 was 37.3 (12.7), n = 508. Spearman correlation between the initial CAS-15 and the initial apnea-hypopnea index (AHI) was 0.41 (95% confidence interval [CI], 0.29, 0.51), n = 212, P < .001. A receiver-operating characteristic curve predicting positive polysomnography (AHI > 2) had an area under the curve of 0.71 (95% CI, 0.63, 0.80). A score ≥ 32 had a sensitivity of 69.0% (95% CI, 61.7, 75.5), a specificity of 63.4% (95% CI, 47.9, 76.6), a positive predictive value of 88.7% (95% CI, 82.1, 93.1), and a negative predictive value of 32.9% (95% CI, 23.5, 44.0) in predicting positive polysomnography. Among children who underwent surgery, the mean change (SD) score was 30.5 (12.6), n = 201, t = 36.85, P < .001, effect size = 3.1. CONCLUSION: This study establishes the generalizability of the CAS-15 as a useful office tool for the evaluation of pediatric sleep-disordered breathing. LEVEL OF EVIDENCE: 2B Laryngoscope, 130:2256-2262, 2020.
引用
- Goldstein NA, Friedman NR, Nardone HC, et al. The Generalizability of the Clinical Assessment Score-15 for Pediatric Sleep-Disordered Breathing. Laryngoscope. 2019. PMID: 31782808. doi:10.1002/lary.28428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。